Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
Benjamin Paul Timothy LovedayJennifer J KnoxLaura A DawsonUr MetserAnthony BradeAnne M HorganSteven GallingerPaul D GreigCarol-Anne MoultonPublished in: Journal of surgical oncology (2018)
Neoadjuvant chemoradiation and liver transplantation for unresectable early stage pCCA is feasible, although with high rates of dropout and disease progression. Further research is required to determine factors to help select patients for treatment.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- early stage
- squamous cell carcinoma
- radiation therapy
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- lymph node
- prognostic factors
- peritoneal dialysis
- liver metastases
- patient reported outcomes
- smoking cessation
- replacement therapy
- patient reported